Format

Send to

Choose Destination
Macromol Biosci. 2017 Oct;17(10). doi: 10.1002/mabi.201600377. Epub 2016 Dec 12.

Reversible Bioconjugation: Biodegradable Poly(phosphate)-Protein Conjugates.

Author information

1
Max-Planck-Institut für Polymerforschung, Ackermannweg 10, 55128, Mainz, Germany.
2
Graduate School Material Science in Mainz, Staudinger Weg 9, 55128, Mainz, Germany.
3
CNR Istituto Officina dei Materiali c/o Institut Laue Langevin, 38000, Grenoble, France.
4
Institut Lumière Matière, Université de Lyon 1, 69622, Lyon, France.

Abstract

Protein-polymer conjugates are widely used to improve the pharmacokinetic properties of therapeutic proteins. Commercially available conjugates employ poly(ethylene glycol) (PEG) as the protective polymer; however, PEG has a number of shortcomings, including non-biodegradability and immunogenicity, that call for the development of alternatives. Here, the synthesis of biodegradable poly(phosphate), that is, poly(ethyl ethylene phosphate) (PEEP), by organo-catalyzed anionic ring-opening polymerization exhibiting dispersity values Ð < 1.3 is reported. Polymers with molecular weights between 2000 and 33 200 g mol-1 are then ω-functionalized with a succinimidyl carbonate group and subsequently conjugated to model proteins. These are the first conjugates based on polyphosphates which degraded upon exposure to phosphodiesterase. As is the case for PEGylated therapeutics, residual in vitro activity of the PPEylated conjugates depends on the extent of protein modification. These results suggest that PEEP exhibits the desired properties of a biopolymer for use in next generation, fully degradable drug delivery systems.

KEYWORDS:

PEGylation; biodegradable polymer; poly(phosphoester)s; protein-polymer conjugates

PMID:
27943530
DOI:
10.1002/mabi.201600377
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center